Erectile dysfunction (ED) medications known as Phosphodiesterase type 5 (PDE-5) inhibitors have been used by millions of men as safe and effective management options associated with high rates of patient and partner satisfaction.
The best way to prevent airborne terrorist attacks may be to improve the baseline security screening of all air travelers rather than identifying and screening high-risk passengers, according to new research by experts at MIT and Harvey Mudd College.
Mark Russo, M.D., M.S., a researcher at Columbia University’s International Center for Health Outcomes and Innovation Research in New York will present findings from a study of the cost of medical management in chronic end-stage heart failure patients. The study found that despite the terminal nature of end-stage heart failure, costs and resource utilization increased dramatically as death approached.
In the largest review of “broken heart syndrome” patients ever conducted, Mayo Clinic researchers studied 100 patients and found symptoms recurred in 1 out of 10 patients over a four-year period, and that patients experiencing physical stress had a worse survival rate than those under emotional stress.
The National Institute of Mental Health, part of the National Institutes of Health, is funding five new research projects that will shed light on antidepressant medications, notably selective serotonin reuptake inhibitors (SSRIs), and their association with suicidal thoughts and actions (suicidality).
ALTRAN, the European leader in innovation and high technology consulting, unveiled at the EcoBuilding Performance Forum on November 8-9 in Paris, three new eco-innovative concepts, to enable the best use of energy in the building and urban environment sectors. The “eco-innovation” is one of the pillars of the environment policy recently adopted by the EU, emphasizing that a “green” product is not enough, but that the product’s life cycle must be energy efficient.
Almost everyone suffers from occasional heartburn, even kids. However, if symptoms are persistent and occur two or more days a week, it could signify a condition known as acid reflux disease, commonly known as GERD, which affects roughly two to eight percent of children in the United States. A recent online survey conducted by StrategyOne found that GERD can have a significant impact on kids? lifestyles, and nearly four in ten (38%) parents wished they had more resources about GERD in children.
Investigators are presenting more than 380 abstracts on preliminary findings in the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Philadelphia, Nov. 9-15. Following are highlights of some key investigations on anaphylaxis, food allergy and insect allergy.
Investigators are presenting more than 380 abstracts on preliminary findings in the diagnosis and treatment of allergic diseases at the ACAAI Annual Meeting in Philadelphia, Nov. 9-15. Following are highlights of some key investigations on allergic asthma.
Abbott and Kos Pharmaceuticals, Inc. today announced a definitive agreement for Abbott to acquire Kos for $78 per share in cash, for a total transaction value of $3.7 billion, net of cash currently held by Kos. Based in Cranbury, N.J., Kos is a specialty pharmaceutical company that develops and markets proprietary medications for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company has a growing presence in the $20 billion lipid management market.